mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.7 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.7 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |